Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Diabetes. Feb 15, 2014; 5(1): 76-83
Published online Feb 15, 2014. doi: 10.4239/wjd.v5.i1.76
Table 4 Treatment of the study population in Greece
Treatmentn (%)
Antidiabetic740 (92.9)
Insulin145 (19.6)
Biguanide (metformin)519 (70.1)
Sulfonylurea343 (46.4)
Glitazone142 (19.2)
Others104 (14.1)
Lipid-lowering553 (69.4)
Statin517 (93.5)
Ezetimibe53 (9.6)
Fibrate17 (3.1)
Others43 (7.8)
Antihypertensive591 (96.11)
ARBs330 (55.8)
ACEi202 (34.2)
CCBs242 (40.9)
Beta-blockers179 (30.3)
Alpha-blockers13 (2.2)
Diuretics220 (37.2)
Others19 (3.2)
Anti-obesity40 (5.0)
Aspirin298 (37.4)